AlphaCore Capital’s iShares US Pharmaceuticals ETF IHE Stock Holding History

AlphaCore Capital’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$268K	Hold	3,090	–	–	0.01%	731
2025 Q4	$262K	Buy	+3,090	New	+$247K	0.01%	863
2025 Q2	–	Sell	-13	Closed	-$917	–	1071
2025 Q1	$917	Buy	+13	New	+$903	﹤0.01%	760
2024 Q1	–	Sell	-900	Closed	-$55.6K	–	254
2023 Q4	$55.6K	Hold	900	–	–	0.01%	274
2023 Q3	$53.4K	Hold	900	–	–	0.01%	268
2023 Q2	$53.7K	Buy	+900	New	+$53.5K	0.01%	243

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

AlphaCore Capital's IHE Position: Q1 2026 in Review

AlphaCore Capital held its iShares US Pharmaceuticals ETF (IHE) position steady in Q1 2026 at 3,090 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #731.

AlphaCore Capital first reported a position in IHE in Q2 2023 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

AlphaCore Capital held 3,090 shares of iShares US Pharmaceuticals ETF worth $268K as of Q1 2026.
AlphaCore Capital left its iShares US Pharmaceuticals ETF share count unchanged in Q1 2026.
iShares US Pharmaceuticals ETF made up 0.01% of AlphaCore Capital's portfolio in Q1 2026, its #731 holding.
AlphaCore Capital first reported a position in iShares US Pharmaceuticals ETF in Q2 2023 and has held it in 6 quarters since.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.